v3.26.1
Unaudited Condensed Consolidated Statements of Changes in Shareholders' Equity (Deficit) - USD ($)
$ in Thousands
Private Placement [Member]
Common Stock [Member]
Private Placement [Member]
Additional Paid-in Capital [Member]
Private Placement [Member]
Retained Earnings [Member]
Private Placement [Member]
Units Offering [Member]
Common Stock [Member]
Units Offering [Member]
Additional Paid-in Capital [Member]
Units Offering [Member]
Retained Earnings [Member]
Units Offering [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
BALANCE (in shares) at Dec. 31, 2024                 8,122,060      
BALANCE at Dec. 31, 2024                 $ 0 $ 86,709 $ (87,084) $ (375)
Private placement, net of issuance costs (in shares)                 547,737      
Private placement, net of issuance costs                 $ 0 1,464 0 1,464
Shares issued - warrants exercised (in shares)                 2,186,595      
Shares issued - warrants exercised                 $ 1 8,827 0 8,828
Shares issued for conversion of Convertible Promissory Note (in shares)                 800,000      
Shares issued for conversion of Convertible Promissory Note                 $ 0 12,329 0 12,329
Shares issues for consulting services (in shares)                 22,344      
Shares issues for consulting services                 $ 0 32 0 32
Share-based compensation expense (in shares)                 0      
Share-based compensation expense                 $ 0 247 0 247
Deemed dividend on warrant inducement (in shares)                 0      
Deemed dividend on warrant inducement                 $ 0 0 (4,410) (4,410)
Net loss                 $ 0 0 (12,930) (12,930)
BALANCE (in shares) at Mar. 31, 2025                 11,678,736      
BALANCE at Mar. 31, 2025                 $ 1 109,608 (104,424) 5,185
BALANCE (in shares) at Dec. 31, 2024                 8,122,060      
BALANCE at Dec. 31, 2024                 $ 0 86,709 (87,084) (375)
Net loss                       (14,763)
BALANCE (in shares) at Jun. 30, 2025                 13,298,838      
BALANCE at Jun. 30, 2025                 $ 1 118,356 (106,257) 12,100
BALANCE (in shares) at Mar. 31, 2025                 11,678,736      
BALANCE at Mar. 31, 2025                 $ 1 109,608 (104,424) 5,185
Private placement, net of issuance costs (in shares)                 340,000      
Private placement, net of issuance costs                 $ 0 1,135 1,135
Shares issued for conversion of Convertible Promissory Note (in shares)                 37,549      
Shares issued for conversion of Convertible Promissory Note                 $ 0 383 0 383
Share-based compensation expense (in shares)                 45,411      
Share-based compensation expense                 $ 0 77 0 77
Deemed dividend on warrant inducement (in shares)                 340,000      
Deemed dividend on warrant inducement                 $ 0 4,410 0 4,410
Net loss                 $ 0 0 (1,833) (1,833)
Shares issued for Evoke acquisition (in shares)                 857,142      
Shares issued for Evoke acquisition                 $ 0 2,743 0 2,743
BALANCE (in shares) at Jun. 30, 2025                 13,298,838      
BALANCE at Jun. 30, 2025                 $ 1 118,356 (106,257) 12,100
BALANCE (in shares) at Dec. 31, 2025                 13,964,367      
BALANCE at Dec. 31, 2025                 $ 1 119,251 (111,615) 7,637
Private placement, net of issuance costs (in shares) 450,967                      
Private placement, net of issuance costs $ 0 $ 2,236 $ 0 $ 2,236                
Shares issued - warrants exercised (in shares)                 300,000      
Shares issued - warrants exercised                 $ 0 150 0 150
Shares issued for conversion of Convertible Promissory Note (in shares)                 0      
Shares issued for conversion of Convertible Promissory Note                 $ 0 0 0 0
Shares issues for consulting services (in shares)                 0      
Shares issues for consulting services                 $ 0 0 0 0
Share-based compensation expense (in shares)                 150,022      
Share-based compensation expense                 $ 0 423 0 423
Deemed dividend on warrant inducement (in shares)                 0      
Deemed dividend on warrant inducement                 $ 0 0 0 0
Net loss                 $ 0 0 (2,004) (2,004)
BALANCE (in shares) at Mar. 31, 2026                 14,865,356      
BALANCE at Mar. 31, 2026                 $ 1 122,060 (113,619) 8,442
BALANCE (in shares) at Dec. 31, 2025                 13,964,367      
BALANCE at Dec. 31, 2025                 $ 1 119,251 (111,615) 7,637
Net loss                       (3,988)
BALANCE (in shares) at Jun. 30, 2026                 15,683,601      
BALANCE at Jun. 30, 2026                 $ 2 130,219 (115,558) 14,663
BALANCE (in shares) at Mar. 31, 2026                 14,865,356      
BALANCE at Mar. 31, 2026                 $ 1 122,060 (113,619) 8,442
Private placement, net of issuance costs (in shares) 762,208                      
Private placement, net of issuance costs $ 1 $ 7,891 $ 0 $ 7,892                
Shares issued for conversion of Convertible Promissory Note (in shares)                 0      
Shares issued for conversion of Convertible Promissory Note                 $ 0 0 0 0
Share-based compensation expense (in shares)         56,037              
Share-based compensation expense         $ 0 $ 268 $ 0 $ 268        
Deemed dividend on warrant inducement (in shares)                 0      
Deemed dividend on warrant inducement                 $ 0 0 0 0
Net loss                 $ 0 0 (1,984) (1,984)
Shares issued for Evoke acquisition (in shares)                 0      
Shares issued for Evoke acquisition                 $ 0 0 0 0
Deconsolidation of Subsidiary                 $ 0 0 45 45
BALANCE (in shares) at Jun. 30, 2026                 15,683,601      
BALANCE at Jun. 30, 2026                 $ 2 $ 130,219 $ (115,558) $ 14,663